The accumulation of misfolded proteins is associated with various neurodegenerative conditions. Peripheral myelin protein 22 (PMP22) is a hereditary neuropathy-linked, short-lived molecule that forms aggresomes when the proteasome is inhibited or the protein is mutated. We previously showed that the removal of pre-existing PMP22 aggregates is assisted by autophagy. Here we examined whether the accumulation of such aggregates could be suppressed by experimental induction of autophagy and/or chaperones. Enhancement of autophagy during proteasome inhibition hinders protein aggregate formation and correlates with a reduction in accumulated proteasome substrates. Conversely, simultaneous inhibition of autophagy and the proteasome augments the formation of aggregates. An increase of heat shock protein levels by geldanamycin treatment or heat shock preconditioning similarly hampers aggresome formation. The beneficial effects of autophagy and chaperones in preventing the accumulation of misfolded PMP22 are additive and provide a potential avenue for therapeutic approaches in hereditary neuropathies linked to PMP22 mutations.
Introduction
In order to maintain cellular homeostasis, different quality control mechanisms evolved which prevent the accumulation of misfolded or nonfunctional polypeptides in aggregates (Goldberg, 2003) . When the correct folding and/or trafficking of a nascent polypeptide fail, the protein is commonly targeted for degradation by the ubiquitin-proteasome system (UPS) (Goldberg, 2003) . The proteasome is an enzymatic complex that contains a catalytic chamber inside of which unfolded polypeptides are degraded (Groll and Clausen, 2003) . In addition to the proteasome, unwanted cytoplasmic proteins can be degraded within lysosomes. Macroautophagy, from here on referred to as autophagy, is a constitutive event by which cytoplasmic cargo is engulfed in double membrane-bound structures called autophagosomes that later fuse with lysosomes, ensuring degradation of the cargo (Klionsky and Emr, 2000) . When the balance between synthesis/ folding and degradation pathways is disrupted, the accumulation of proteins in aggregates is favored, which constitutes the pathological hallmark of several neurodegenerative conditions (Ciechanover and Brundin, 2003) .
Peripheral myelin protein 22 (PMP22) is a hydrophobic, aggregation-prone, membrane protein expressed mainly in myelinating Schwann cells (SCs) (Snipes et al., 1992; Tobler et al., 2002) . In non-myelinating and myelinating SCs, the majority (~80%) of the newly synthesized PMP22 is rapidly degraded by the UPS, presumably due to misfolding (Pareek et al., 1997) . Mutations in PMP22, or duplication of the PMP22 gene, are associated with hereditary demyelinating neuropathies among which, Charcot-Marie-Tooth type 1A (CMT1A) is the most common form (Young and Suter, 2001) . Although the molecular mechanisms underlying CMT1A are not well understood, halted intracellular protein trafficking and formation of aggregates are believed to play roles (D'Urso et al., 1998; Tobler et al., 1999; Naef and Suter, 1999; Colby et al., 2000; Fortun et al., 2003 Fortun et al., , 2006 . In SCs of CMT1A mouse models, the spontaneous Abbreviations: PMP22, peripheral myelin protein 22; SC, Schwann cell; wt, wild type; HSP, heat shock protein; Lc, lactacystin; DMSO, dimethylsulfoxide; Stv, starvation; 3-MA, 3-methyladenine; GA, geldanamycin; HS, heat shock; GFP, green fluorescent protein; CMT1A, CharcotMarie-Tooth disease type 1A; P, postnatal; UPS, ubiquitin-proteasome system; CMA, chaperone-mediated autophagy.
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